Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells

Nat Med. 2001 Oct;7(10):1111-7. doi: 10.1038/nm1001-1111.

Abstract

Loss of p53 gene function, which occurs in most colon cancer cells, has been shown to abolish the apoptotic response to 5-fluorouracil (5-FU). To identify genes downstream of p53 that might mediate these effects, we assessed global patterns of gene expression following 5-FU treatment of isogenic cells differing only in their p53 status. The gene encoding mitochondrial ferredoxin reductase (protein, FR; gene, FDXR) was one of the few genes significantly induced by p53 after 5-FU treatment. The FR protein was localized to mitochondria and suppressed the growth of colon cancer cells when over-expressed. Targeted disruption of the FDXR gene in human colon cancer cells showed that it was essential for viability, and partial disruption of the gene resulted in decreased sensitivity to 5-FU-induced apoptosis. These data, coupled with the effects of pharmacologic inhibitors of reactive oxygen species, indicate that FR contributes to p53-mediated apoptosis through the generation of oxidative stress in mitochondria.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology*
  • Apoptosis*
  • Cell Division / drug effects
  • Colorectal Neoplasms
  • Ferredoxin-NADP Reductase / genetics
  • Ferredoxin-NADP Reductase / physiology*
  • Flow Cytometry
  • Fluorouracil / pharmacology*
  • Gene Expression / drug effects
  • Gene Targeting / methods
  • Humans
  • Oxidative Stress
  • Recombination, Genetic
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Antimetabolites, Antineoplastic
  • Tumor Suppressor Protein p53
  • Ferredoxin-NADP Reductase
  • Fluorouracil